Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES AUROBINDO PHARMA ZYDUS LIFESCIENCES/
AUROBINDO PHARMA
 
P/E (TTM) x 20.0 14.0 142.9% View Chart
P/BV x 2.4 1.4 172.0% View Chart
Dividend Yield % 0.6 1.6 40.3%  

Financials

 ZYDUS LIFESCIENCES   AUROBINDO PHARMA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-22
AUROBINDO PHARMA
Mar-22
ZYDUS LIFESCIENCES/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs6741,064 63.3%   
Low Rs331584 56.7%   
Sales per share (Unadj.) Rs149.1400.3 37.2%  
Earnings per share (Unadj.) Rs22.745.7 49.7%  
Cash flow per share (Unadj.) Rs29.764.9 45.7%  
Dividends per share (Unadj.) Rs2.509.00 27.8%  
Avg Dividend yield %0.51.1 45.6%  
Book value per share (Unadj.) Rs166.1419.4 39.6%  
Shares outstanding (eoy) m1,023.74585.94 174.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.42.1 163.7%   
Avg P/E ratio x22.118.0 122.6%  
P/CF ratio (eoy) x16.912.7 133.3%  
Price / Book Value ratio x3.02.0 154.0%  
Dividend payout %11.019.7 55.9%   
Avg Mkt Cap Rs m514,277482,799 106.5%   
No. of employees `000NANA-   
Total wages/salary Rs m21,77734,509 63.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m152,652234,555 65.1%  
Other income Rs m2,3543,226 73.0%   
Total revenues Rs m155,006237,781 65.2%   
Gross profit Rs m34,42742,566 80.9%  
Depreciation Rs m7,13011,265 63.3%   
Interest Rs m1,270486 261.1%   
Profit before tax Rs m28,38134,040 83.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,1177,256 70.5%   
Profit after tax Rs m23,26426,784 86.9%  
Gross profit margin %22.618.1 124.3%  
Effective tax rate %18.021.3 84.6%   
Net profit margin %15.211.4 133.5%  
BALANCE SHEET DATA
Current assets Rs m122,614181,227 67.7%   
Current liabilities Rs m78,39481,560 96.1%   
Net working cap to sales %29.042.5 68.2%  
Current ratio x1.62.2 70.4%  
Inventory Days Days9325 370.0%  
Debtors Days Days8062 127.9%  
Net fixed assets Rs m144,382155,104 93.1%   
Share capital Rs m1,024586 174.8%   
"Free" reserves Rs m168,972245,174 68.9%   
Net worth Rs m169,996245,760 69.2%   
Long term debt Rs m3,6212,492 145.3%   
Total assets Rs m266,996336,331 79.4%  
Interest coverage x23.371.0 32.9%   
Debt to equity ratio x00 210.1%  
Sales to assets ratio x0.60.7 82.0%   
Return on assets %9.28.1 113.3%  
Return on equity %13.710.9 125.6%  
Return on capital %17.113.9 122.8%  
Exports to sales %031.1 0.0%   
Imports to sales %14.311.9 120.2%   
Exports (fob) Rs mNA72,862 0.0%   
Imports (cif) Rs m21,86927,965 78.2%   
Fx inflow Rs m63,06577,245 81.6%   
Fx outflow Rs m21,86931,524 69.4%   
Net fx Rs m41,19645,721 90.1%   
CASH FLOW
From Operations Rs m21,04150,165 41.9%  
From Investments Rs m11,544-32,116 -35.9%  
From Financial Activity Rs m-8,683-29,693 29.2%  
Net Cashflow Rs m23,729-11,674 -203.3%  

Share Holding

Indian Promoters % 74.9 48.8 153.6%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 14.9 38.0 39.1%  
FIIs % 2.9 20.7 13.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.1 48.2 52.1%  
Shareholders   455,624 359,684 126.7%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   DR. REDDYS LAB    SUN PHARMA    CIPLA    LUPIN    PIRAMAL ENTERPRISES    



Today's Market

Sensex Zooms 418 Points, Nifty Ends Above 17,900; Bajaj Twins and Bharti Airtel Rally(Closing)

After opening the day on a flat note, Indian share markets extended gains as the session progressed and ended near day's high.